A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects

Oncology

Volumn 56, Issue 3, 1999, Pages 181-188

  Fracchia, Antonio ^a   Ubbiali, Alessandro ^a   El Bitar, Omar ^a   Pacetti, Miriam ^a   Sommariva, Emanuela ^a   Arreghini, Marco ^a   Longhini, Erminio ^a   Bonalumi, Giovanni Paolo ^a  

^a Osp 'Citta di Sesto S Giovanni'   (Italy)

Author keywords

Bronchoalveolar lavage; Ferritin; Lung cancer; Tumor marker

Indexed keywords

FERRITIN; REAGENT; TUMOR MARKER;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; LUNG CANCER; LUNG CARCINOMA; LUNG DISEASE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SMOKING;

EID: 0032957365     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011962     Document Type: Article

References (39)

1. Niklinski J, Furman M: Clinical tumour markers in lung cancer (109 refs). Eur J Cancer Prevent 1995;4:129-138.
2. Worwood M: Ferritin in human tissues and serum. Clin Haematol 1982;11:275-307.
3. Giler S, Moroz C: The significance of ferritin in malignant diseases. Biomedicine 1978;28:203-206.
4. Konijn AM, Hershko C: The anaemia of inflammation and chronic disease; in De Souza M, Brock JH (eds): Iron in Immunity, Cancer and Inflammation. Chichester, Wiley, 1989, p 111.
5. Lombardi C, Tassi GF, Pizzocollo G, Donato F: Clinical significance of a multiple biomarker assay in patients with lung cancer. Chest 1990; 97:639-644.
6. Gail MH, Muenz L, McIntire KR, Radovich B, Braunstein G, Brown PR, Deftos L, Dnistrian A, Dunsmore M, Elashoff R, Geller N, W Go VL, Hirji K, Klauber MR, Pee D, Petroni G, Schwanz M, Wolfsen AR: Multiple markers for lung cancer diagnosis: Validation of models for localized lung cancer. J Natl Cancer Inst 1988; 80:97-101.
7. Ferrigno D. Buccheri GF: Serum ferritin levels in lung cancer patients (letter). Eur J Cancer 1992;28:241.
8. Buccheri GF, Violante B, Sartoris AM, Ferrigno D, Curcio A, Vola F: Clinical value of multiple biomarker assay in patients with bronchogenic carcinoma. Cancer 1986;57: 2389-2398.
9. Bianco A, Marcatili P, D'Auria D, Sorrentino P, Zofra S: Blood tumor markers in patients with lung cancer. Ann Ital Med Interna 1996; 11:114-118.
10. Alvarez Sala R, Blasco R, Callol L, Laguna R, Alvarez Sala JL, Gomez De Terreras FJ: Tumor markers in bronchoalveolar lavage. Acta Oncol (Stockh) 1989;28:290-291.
11. Macchia V, Mariano A, Cavalcanti M, Coppa A, Cecere C, Fraiolo G, Elia S, Ferrante G: Tumor markers and lung cancer: Correlation between serum and bronchial secretion levels of CEA, TPA, CanAg CA-50, NSE and ferritin. Int J Biol Markers 1987;2:151-156.
12. Schultek T, Braun J, Wiessmann KJ, Wood WG: Bronchoalveolar lavage: The umoral parameter spectrum in bronchial carcinoma and chronic bronchitis. Dtsch Med Wochenschr 1986;111:333-337.
13. Son CH, Lee MK, Hong TJ, Chung WT, Park SK, Shin YK: Measurements of carcinoembryonic antigen and ferritin levels in the serum and bronchoalveolar lavage fluid in patients with pulmonary disease. Tuberc Respir Dis 1988;35:92-102.
14. Maxim PE, Veltri RW, Sprinkle PM: Soluble tumor-associated markers in lung cancer extracts. Oncololgy 1981;38:147-153.
15. Mountain CF: Revision in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717.
16. Klech H, Pohl W: Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Resp J 1989;2:561-585.
17. Auble D: Extended tables for the Mann-Whitney statistic. Bull Inst Educ Res Indiana University, 1953, vol 1.
18. Goldstein N, Lippmann ML, Goldberg SK, Fein AM, Shapiro B, Leon SA: Usefulness of markers in serum and bronchoalveolar lavage of patients undergoing fiberoptic bronchoscopy. Am Rev Respir Dis 1985;132:60-64.
19. Nelson ME, O'Brien-Ladner AR, Wesselius LJ: Regional variation in iron and iron-binding proteins within the lungs of smokers. Am J Resp Crit Care Med 1996;153:1353-1358.
20. Stevens R, Richard G, Kalkwarf DR: Iron, radiation and cancer. Envir Hlth Perspect 1990;87:291-300.
21. Gayton KZ, Kensler TW: Oxidative mechanisms in carcinogenesis. Br Med Bull 1993;49: 523-544.
22. Cerutti PA: Prooxidant states and tumor promotion. Science 1985;229:375-381.
23. Feig DI, Reid TM, Loeb LA: Reactive oxygen species in tumorigenesis. Cancer Res 1994; 54(suppl):1890-1894.
24. Cazzola M, Bergamaschi G, Dezza L, Arosio P: Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects. Blood 1990;75:1903-1919.
25. Reizenstein P: Iron, free radicals and cancer. Med Oncol Tumor Pharmacother 1991;8:229-233.
26. Weinberg ED: Cellular iron metabolism in health and disease. Drug Metab Rev 1990;22: 531-579.
27. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 2. Oxford, Oxford University Press, 1989.
28. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90:7915-7922.
29. Gutteridge JMC, Halliwell B: Iron toxicity and oxygen radicals. Clin Haematol 1989;2:195-256.
30. Ryrfeldt A, Bannenber G, Moldus O: Free radicals and lung disease. Br Med Bull 1993;49: 588-603.
31. Thompson AB, Bohling T, Heires A, Linder J, Rennard SI: Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med 1991;117:493-499.
32. Thompson AB, Bohling T, Payvandi F, Rennard SI: Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med 1990;115:148-158.
33. Corhay JL, Weber G, Bury Th, Mariz S, Roelandts I, Radermecker MF: Iron content in human alveolar macrophages. Eur Respir J 1992;5:804-809.
34. Dietemann-Molard A, Maier E, Pelletier A, Hutt N, Maier A, Bohner C, Pauli G, Leroy MJF, Roegel E: Etude multiélémentaire des composants inorganiques due liquide de lavage bronchoalvéolaire chez le sujet normal et dans diverses pathologies pulmonaires. Rev Mal Respir 1989;6:511-517.
35. McGowan SE, Henley SA: Iron and ferritin contents and distribution in human alveolar macrophages. J Lab Clin Med 1988;111:611-617.
36. Wesselius LJ, Flowers CH, Skikne BS: Alveolar macrophage content of isoferritins and transferrin: A comparison of non-smokers and smokers with and without chronic airflow obstruction. Am Rev Respir Dis 1992;145:311-316.
37. Mims CA: The Pathogenesis of Infectious Diseases. London/New York, Academic Press/ Grune & Stratton, 1976, p 213.
38. Braude AI: Mechanisms of natural resistance to infections; in Braude AI, Davis CE, Fierer J (eds): Medical Microbiology and Infectious Disease, Philadelphia, Saunders, 1981, pp 739-764.
39. Beisel WR: Metabolic effect of infection; in Braude AI, Davis CE, Fierer J (eds): Medical Microlbiology and Infectious Disease. Philadelphia, Saunders. 1981, pp 803-808.